Company
Arrivo
Meaningful Outcomes for Longer, Healthier Lives
Also known as Arrivo BioVentures, ARRIVO BIOVENTURES, LLC
- Status
- Operatingas of 2026-09-17
- Business model
- B2B
- Headquarters
- Morrisville, NC, United States
- Legal name
- ARRIVO BIOVENTURES, LLC
Claim, correct or request removal
Record updated 28 September 2026
About
Arrivo is developing first-of-its-kind medicines for hard-to-treat diseases, targeting the diseases at their source to achieve meaningful outcomes for patients to live longer, healthier lives.
Funding snapshot
- Total raised
- $43.2MSEC form D sum, as of 2026-09-28Source (opens in a new tab)
- Latest round
- Round, $43.2M2023-11-17
Funding rounds
- Round, 2023
- $43.2M2023-11-17, SEC form D sold, 58 investors
- Round, 2016
- $49M2016-05-10, SEC form D sold, 34 investors
Products
- Other
- Forvisirvat (SP-624)
- Other
- RABI-767
Loading relationship preview